https://jualslotcaramasakg.wixsite.com/pantrymagic Slot Gacor Gampang Menang Situs Slot Gacor https://gms.dpe.go.th/mobile/public/admin/ckfinder/plugins/fileeditor/situs-judi-slot-terbaik-dan-terpercaya-no-1/ https://geokur-dmp.geo.tu-dresden.de/uploads/user/2022-12-12-182312.459691situs-slot-gacor.html https://geokur-dmp.geo.tu-dresden.de/uploads/user/2022-12-12-183122.222613slot-gacor-gampang-menang.html http://www.digi.vibeunited.co.id/forum/profile/bocoran-slot-gacor-hari-ini/ https://cungtenhanoi.com/2022/12/30/bocoran-pola-jam-hoki-main-slot-gacor-hari-ini-terbaru-gampang-menang-jackpot-terbesar-2022/
Business

Gilead is planning to send arthritis drug to the FDA this year




Gilead Sciences Inc.

GILD, + 0.40%

announced Monday afternoon that it plans to ask the food and drug administration to approve an arthritis this year. Gilead, in collaboration with Galapagos NV

GLPG, + 1.17%

has tested a substance known as filgotinib for rheumatoid arthritis, and recent study results ate investors in March. In a press release on Monday, Gilead said it met the FDA to discuss these test results recently. "As a result of this discussion, a way forward has been established to submit the NDA for filgotinib as a treatment for rheumatoid arthritis in 201[ads1]9," the release says.



Source link

Back to top button